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Abstract
Background: The genetic contributions to human common disorders and mouse genetic models of disease are
complex and often overlapping. In common human diseases, unlike classical Mendelian disorders, genetic factors
generally have small effect sizes, are multifactorial, and are highly pleiotropic. Likewise, mouse genetic models of
disease often have pleiotropic and overlapping phenotypes. Moreover, phenotypic descriptions in the literature in
both human and mouse are often poorly characterized and difficult to compare directly.
Methods: In this report, human genetic association results from the literature are summarized with regard to
replication, disease phenotype, and gene specific results; and organized in the context of a systematic disease
ontology. Similarly summarized mouse genetic disease models are organized within the Mammalian Phenotype
ontology. Human and mouse disease and phenotype based gene sets are identified. These disease gene sets are
then compared individually and in large groups through dendrogram analysis and hierarchical clustering analysis.
Results: Human disease and mouse phenotype gene sets are shown to group into disease and phenotypically
relevant groups at both a coarse and fine level based on gene sharing.
Conclusion: This analysis provides a systematic and global perspective on the genetics of common human disease
as compared to itself and in the context of mouse genetic models of disease.
Background
Common complex diseases such as cardiovascular dis-
ease, cancer, and autoimmune disorders; metabolic con-
ditions such as diabetes and obesity, as well as
neurological and psychiatric disorders make up a major-
ity of health morbidity and mortality in developed coun-
tries. The specific genetic contributions to disease
etiology and relationships to environmental factors in
common disorders are unclear; complicated by many
factors such as gene-gene interactions, the balance
between susceptibility and protective alleles, copy num-
ber variation, low relative risk contributed by each gene,
and a myriad of complex environmental inputs.
Genetic association studies using a candidate gene
approach and more recently whole genome association
studies (GWAS) have produced a large and rapidly
increasing amount of information on the genetics of
common disease. In parallel, mouse genetic models for
human disease have provided a wealth of genetic and
phenotypic information. While not always perfect mod-
els for human common complex disorders, the genetic
purity and experimental flexibility of mouse disease
models have produced valuable insights relevant to
human disease.
Gene nomenclature standardization[1], database
efforts [2-4], and phenotype ontology projects[5] in both
human and mouse over the past decade have provided
the foundation for integration of information on genetic
contributions to disease and phenotypes. This allows the
opportunity for systematic comparison and higher order
systems analysis of disease and phenotypic information.
In this report, we summarize and integrate large scale
information on human genetic association information
and mouse genetically determined phenotypic informa-
tion with the goal of identifying fundamental
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Methods
The Genetic Association Database
The Genetic Association Database [2] (GAD) http://
geneticassociationdb.nih.gov is an archive of summary
data of published human genetic association studies of
many common disease types. GAD is primarily focused
on archiving information on common complex human
disease rather than rare Mendelian disorders as found in
the Online Mendelian Inheritance in Man (OMIM)[6].
GAD contains curated information on candidate gene
studies and more recently on genome wide association
studies. It builds on the curation of the CDC HuGENet
info literature database [3] in part by adding molecular
and ontological annotation creating a bridge between
epidemiological and molecular information. This allows
the large-scale integration of disease based genetic asso-
ciation information with genomic and molecular infor-
mation as well as with the software tools and
computational approaches and that use genomic infor-
mation [7-12]. This report is a summary and analysis of
the genes and diseases with positive associations in the
Genetic Association Database with regard to replication,
comparisons between diseases, and within broad pheno-
typic disease classes. Although GAD contains informa-
tion on gene variation, this report is at the gene level
only and does not consider specific gene variation or
genetic polymorphism.
The Genetic Association Database (GAD) currently
contains approximately 40,000 individual gene records of
genetic association studies taken from over 23,000 inde-
pendent publications. Importantly, a large number
(11,568) of the records in GAD have a designation of
whether the gene of record was reported to be associated
(Y) or was not (N) associated with the disease phenotype
for that specific record. Many records, for various rea-
sons, do not have such a designation. In addition, a por-
tion of the database records have been annotated with
standardized disease phenotype keywords from the
MeSH http://www.nlm.nih.gov/mesh/ vocabulary. The
GAD summations shown below are a subset of the
records in GAD. They only include those records that are
both; a) positively associated with a disease phenotype,
and b) have a MeSH disease phenotype annotation. This
represents a subset of 10,324 records having both positive
associations to disease and records with MeSH annota-
tions. Records designated as not associated (N) with a
disease phenotype and those without MeSH disease
annotation are not considered at this time in this report.
Mouse phenotypic database
The mouse phenotypic information described here was
obtained from the Mouse Genome Informatics (MGI)
database [4]http://www.informatics.jax.org/ Phenotypes,
Alleles and Disease Models section. The file used for
mouse phenotypic information (see methods) is com-
prised of 5011 unique genes and 5142 unique phenoty-
pic terms derived from information from specific gene
mutations in multiple mouse strains. The mouse pheno-
typic information had been annotated to the mouse
gene mutation records using Mammalian Phenotype
terms and codes in the mouse phenotype database as a
component of the Mouse Phenotyping Project [5,13].
Quantitation of genes and disease phenotypes
Quantitation of how often a disease phenotype was posi-
tively associated with a gene was performed as follows.
GAD records having both recorded positive associations
and annotated MeSH disease keywords were extracted
and stored in a database according to their relationships.
Using a perl script, the number of times of co-occur-
rence of a MeSH disease keyword was positively asso-
ciated with a specific gene was recorded as found in the
GAD database. These counts were sorted in declining
order for each unique gene grouped by the disease
MeSH term with which they are associated.
Mouse phenotypic information
The mouse phenotypic information described here was
obtained from the Mouse Genome Informatics (MGI)
http://www.informatics.jax.org/; Phenotypes, Alleles and
Disease Models section; ftp://ftp.informatics.jax.org/pub/
reports/index.html#pheno
Using these three files downloaded on 4-4-2008ftp://
ftp.informatics.jax.org/pub/reports/MPheno_OBO.onto-
logyftp://ftp.informatics.jax.org/pub/reports/MGI_Pheno-
typicAllele.rptftp://ftp.informatics.jax.org/pub/reports/
MGI_PhenoGenoMP.rpt
The mouse phenotype files were extracted using a perl
script annotating each gene with the phenotype term
associated with each Mammalian Phenotype (MP) code.
Venn Diagram overlap of individual gene lists
Individual GAD primary gene sets were analyzed using
Venny[14]http://bioinfogp.cnb.csic.es/tools/venny/index.
html. Pathway Venn Diagram comparisons were per-
formed by placing individual GAD primary gene sets
into WebGestalt [15]http://bioinfo.vanderbilt.edu/web-
gestalt/ to identify KEGG pathways, then placing the
resulting pathway names into Venny.
Dendrogram analysis of gene sets
Relationships between diseases were identified by a
unique method similar to phyologenetic classification.
First the distance between the diseases were calculated
by pairwise comparison of the diseases by finding the
common genes between the pairs and dividing it by the
smallest group of the pair. This number was then sub-
tracted from 1. This step was done because if two lists
are identical (100% match) then the resultant distance
should be 0. This is represented in the formula:
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The disease relationships were calculated from the dis-
tance matrix using the Fitch program from the Phylip
package[16]. It calculates the relationships based on the
Fitch and Margoliash method of constructing the phylo-
genetic trees[17] using the following formula (from the
Phylip manual):
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where D is the observed distance between gene sets i
and j and d is the expected distance, computed as the
sum of the lengths of the segments of the tree from gene
set i to gene set j. The quantity n is the number of times
each distance has been replicated. In simple cases n is
t a k e nt ob eo n e .I fn is chosen more than 1, the distance
is then assumed to be a mean of those replicates. The
power P is what distinguished between the Fitch and
Neighbor-Joining methods. For the Fitch-Margoliash
method P is 2.0 and for Neighbor-Joining method it is
0.0. As running Fitch took a long time when the gene-set
size was huge (weeks for the human gene-sets and
months for the mouse gene-sets), Neighbor-Joining
method was used to create the replicate dendrograms
(not shown) after randomizing the input order for greater
confidence. The resulting coefficient matrix files were
displayed using the Phylodraw graphics program[18].
Hierarchical clustering of gene sets
Ward’s minimum variance method[19] was used to find
the distance between two diseases. The distance between
the clusters is the ANOVA sum of squares between the
two clusters added up over all the variables. At each
generation, the within-cluster sum of squares is mini-
mized over all partitions obtainable by merging two
clusters from the previous generation. Ward’sm e t h o d
joins clusters to maximize the likelihood at each level of
the hierarchy under the assumptions of multivariate
normal mixtures, spherical covariance matrices, and
equal sampling probabilities. Distance for Ward’s
method is: DKL
xK xL
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

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11 (taken from JMP Manual)
where NK is the number of observations in CK (which is
the Kth cluster, subset of {1, 2, ..., n) where n is the
number of observations). xk is the mean vector for
cluster CK.
Results
Each record in GAD represents a specific gene from a
unique publication of a human population based genetic
association study and is categorized into one of 24 gen-
eral disease classes corresponding to broad MeSH dis-
ease or disease phenotypic groupings. Table 1 is a
summary of the number of positively associated human
genes in each MeSH human disease class. As repre-
sented by these disease classes the GAD database covers
a broad selection of diseases falling into major disease
classes including; aging studies, cancer, immune disor-
ders, psychiatric diseases, metabolic conditions, pharma-
cogenomic studies, and studies of chemical dependency,
among others. Similarly, each record in the phenotype
files from the MGI phenotype database represents a
u n i q u em o u s eg e n es p e c i f i cg e n e t i cm o d e l .T a b l e2
shows the general categories represented by the mouse
phenotype summary files and the number of mouse
genes found in each top level phenotype class. The
mouse files contain a greater number of intermediate
developmental and morphological phenotypes (e.g. insu-
lin resistance, absent CD4+ T cells, abnormal spatial
learning) while the human files tend to comprise a
greater number of end stage clinical disease phenotypes
(e.g. Type 2 Diabetes, multiple sclerosis, autism).
Table 3 introduces examples of human genes from
fundamental biological pathways that have been consis-
tently associated with major disease phenotypes high-
lighting the sometimes-broad pleiotropic effects that
major regulatory molecules have on multiple disease
phenotypes. Genes such as NOS3,n i t r i co x i d es y n t h a s e
3, regulating nitrous oxide production; HLA-DQB1,t h e
MHC class II molecule DQ beta 1, involved in antigen
presentation; ACE, angiotensin I converting enzyme,
central to the renin-angiotensin system and PPARG,
peroxisome proliferator-activated receptor gamma, regu-
lating transcription in pathways important in lipid meta-
bolism are examples of genes that affect multiple tissues
and different organ systems through the complex course
of disease progression. Importantly, all the mouse ortho-
logs of the human genes in Table 3 have experimentally
determined phenotypes that are similar or broadly over-
lapping with human clinical disease phenotypes (see
below).
Summaries of genes and phenotypes in human and
mouse
The majority of this report is built upon large non-
redundant general summary lists for both human and
mouse, shown below. These lists take two complimen-
tary forms in both human and mouse. The first sets are
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dant lists of genes showing the diseases or phenotypes
that have been associated with each gene (Table 4
human, table 5 mouse, and table 6 human-mouse). The
second sets of basic lists are DISEASE/PHENOTYPE-to-
Gene lists. These are non redundant lists of diseases or
phenotypes with the genes that have been associated
with that disease or phenotype (Table 7 human and
table 8 mouse).
Human
Table 4 shows examples of selected genes in each row
that have been positively associated with specific disease
phenotype keywords. Each human gene symbol is fol-
lowed by a specific MeSH disease term and the number
of times that gene has been positively associated with
the term, in declining order. A major feature of Table 4
is that individual genes have been positively associated
with sometimes overlapping disease phenotypes over a
broad range from more frequently to less frequently.
Table 4 is a small representative subset, truncated in the
number of genes (rows) and the number of MeSH
terms (columns). The complete list of 1,584 human
genes with additional information can be found in Table
S 1 a[ 2 0 ] .A ni n t e r a c t i v ev e r s i o no ft h es a m el i s tc a nb e
found in Table S1b[21].
Quite often the resulting list of phenotypes associated
with a specific gene may include the major disease phe-
notype followed by specific sub-phenotypes of the disease
that contribute distinct aspects to the overall clinical dis-
ease phenotype. For example, IL13 has been associated
with asthma at least 11 times as well as to the asthma
sub-phenotype immediate hypersensitivity 4 times. Simi-
larly, the gene CFH has been associated with macular
degeneration at least 19 times, as well as to the endo-
phenotype of macular degeneration, choroidal neovascu-
larization 3 times. Although replication in genetic asso-
ciation studies has been widely debated[22], consistent
replication by independent groups, although sometimes
with both modest risk and significance values[23], sug-
gests a fundamental measure of scientific validity. This is
true for both candidate gene as well as GWAS studies.
In other cases, individual genes have been associated
with independent but related disorders that may share
fundamental biological pathways in disease etiology, such
as HLA-DQB1, CTLA4, and PTPN22 as in the case of
autoimmune disorders. This gene overlap emphasizes the
fundamental, often step-wise biochemical role each gene
plays in shared disease etiology [24-27]. That is, HLA-
DQB1 in antigen presentation, CTLA4 in regulation of
the expansion of T cell subsets, and PTPN22 in T cell
receptor signaling, all contributing to immunological
Table 1 Number of human genes associated in each Disease Class
DISEASE CLASS # of human genes in each disease class
Neoplasms 1835
Cardiovascular Diseases 1112
Pathological Conditions, Signs and Symptoms 938
Nervous System Diseases 902
Nutritional and Metabolic Diseases 838
Mental Disorders 554
Digestive System Diseases 407
Male Urogenital Diseases 396
Musculoskeletal Diseases 366
Respiratory Tract Diseases 362
Bacterial Infections and Mycoses 256
Disorders of Environmental Origin 243
Female Urogenital Diseases and Pregnancy Complications 226
Virus Diseases 224
Skin and Connective Tissue Diseases 212
Hemic and Lymphatic Diseases 183
Eye Diseases 176
Congenital, Hereditary, and Neonatal Diseases and Abnormalities 142
Stomatognathic Diseases 130
Immune System Diseases 116
Endocrine System Diseases 98
Parasitic Diseases 57
Otorhinolaryngologic Diseases 35
Animal Diseases 4
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rheumatoid arthritis, systemic lupus erythematosus, and
type 1 diabetes. In other cases, the same gene has been
associated with quite different clinical phenotypes, sug-
gesting sharing of complex biological mechanisms at a
more underlying level. Fore x a m p l e ,t h eg e n eC F T R ,
widely recognized as the cause of cystic fibrosis, has been
consistently associated with pancreatitis, may be impli-
cated in chronic rhinitis [28], and may play a protective
role in gastrointestinal disorders [29].
Mouse
Tables 5 and S2 are the mouse equivalents of the human
GENE-to-Disease/Phenotype lists (tables 4 and S1 for
human). These were developed from the mouse
phenotype table of genes with mouse phenotype ontolo-
gical codes ftp://ftp.informatics.jax.org/pub/reports/
index.html#pheno, downloaded on 4-4-08. To build
tables 5 and S2, the matching phenotypic terms were
exchanged for each Mammalian Phenotype code (MP:#).
This resulted in the mouse GENE-to-Disease/Phenotype
tables (tables 5 and S2) similar in structure to human
GENE-to-Disease/Phenotype tables (tables 4 and S1).
Unlike the human tables, the mouse GENE-to-Disease/
Phenotype tables come from individual mouse experi-
mental knockout or other genetic studies. They are not
based on population based epidemiological studies. They
also do not have the quantitative aspect of the human
tables with publication frequency counts tagged to each
record. In addition, althoug ht h e yi n c l u d eaw i d ev a r i e t y
of physiological, neurological, and behavioral phenotypes,
they do emphasize developmental studies and observa-
tional morphological phenotypes common in mouse
knockout studies. Table 5 is a small representative subset,
truncated in the number of genes (rows) and the number
of Phenotype terms (columns). The complete list of 5011
mouse genes with annotated phenotypes and additional
information can be found in Table S2a[30]. An interac-
tive version of the same list can be found in Table S2b
[31].
Direct comparison of human and mouse genes disease/
phenotypes
We can now compare these tables directly, thereby
allowing gene-by-gene comparison of human disease
phenotypes and mouse genetic phenotypes. Tables 6
and S3 are comparisons of the genes that overlap
between the human and mouse gene lists (Table S1 and
Table S2) showing mouse gene symbols and their
human orthologs. Table 6 is a small subset of selected
gene-phenotype cross species comparisons. Even though
in some cases the human studies have not been repli-
cated, there is often a striking concordance between
human disease phenotypes and mouse genetically deter-
mined phenotypes. For example, the human gene inhi-
bin alpha (INHA) has been associated with premature
ovarian failure[32], and shows mouse phenotypes of
abnormal ovarian follicle morphology, female infertility,
and ovarian hemorrhage[33], among other phenotypes
relevant to human disease. Similarly, in humans the
engrailed homeobox 2 gene (EN2) has been associated
with autistic disorder[34] while the comparison to
mouse En2 has genetic mutations involved in abnormal
social integration, spatial learning, and social/consecu-
tive interaction, among others[35]. Importantly, the few
mouse studies highlighted above, and many found in the
main table S3, were published after the corresponding
human genetic population based epidemiological studies.
Given concerns of false positives and publication bias in
human genetic association studies, direct comparisons
Table 2 Number of Mouse genes in each General
Phenotypic Class
PHENOTYPIC CLASS # of Mouse genes in each class
unassigned top level 19186
nervous system phenotype 8149
immune system phenotype 6414
homeostasis/metabolism phenotype 5976
skeleton phenotype 5559
growth/size phenotype 5556
behavior/neurological phenotype 5417
cardiovascular system phenotype 5221
hematopoietic system phenotype 5163
reproductive system phenotype 4762
lethality-prenatal/perinatal 4409
embryogenesis phenotype 3416
skin/coat/nails phenotype 3048
vision/eye phenotype 2710
hearing/vestibular/ear phenotype 2447
muscle phenotype 2370
cellular phenotype 2335
normal phenotype 2120
renal/urinary system phenotype 2104
endocrine/exocrine gland
phenotype
1871
life span-post-weaning/aging 1857
respiratory system phenotype 1832
digestive/alimentary phenotype 1780
lethality-postnatal 1777
liver/biliary system phenotype 1498
limbs/digits/tail phenotype 1282
tumorigenesis 1268
adipose tissue phenotype 1067
craniofacial phenotype 1016
pigmentation phenotype 634
touch/vibrissae phenotype 625
no phenotypic analysis 403
other phenotype 343
taste/olfaction phenotype 156
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evidence that a given gene may be relevant to a specific
human disease phenotype. Table S3[36] is a full listing
of the 1104 shared genes between the human disease
and mouse phenotype summaries.
Summaries of phenotypes and genes in human and
mouse
The second type of main summary tables are DISEASE/
PHENOTYPE-to-Gene lists. Disease/Phenotype gene
summaries are essentially transposed versions of the
GENE-to-Disease/Phenotype summaries (Tables S1 &
S2) that allow different types of comparisons. These are
non-redundant lists of phenotype keywords, MeSH dis-
ease terms in the case of human and Mammalian Phe-
n o t y p eT e r m s( M P )i nt h ec a s eo fm o u s e ,f o l l o w e db y
the genes associated or annotated to those disease phe-
notype keywords.
Human
Table 7 shows examples of selected human disease phe-
notypes in each row positively associated with specific
human genes for 8 major MeSH disease classes
including cardiovascular, digestive system diseases, dis-
eases of environmental origin, immune system diseases,
mental disorders, nervous system diseases, nutritional
and metabolic diseases, and eye diseases. Each Mesh
phenotype term is followed by the number of times that
a specific disease term has been positively associated
with a particular gene in each row, in decreasing order.
Table 7 is a small representative set, truncated in the
number of disease phenotypes (rows) and the number of
genes (columns). The complete list of 1,318 MeSH dis-
ease phenotype terms with additional information can
be found in Table S4a[37]. An interactive version of the
complete list can be found in Table S4b[38].
Mouse
Tables 8 and S5 constitute the mouse DISEASE/PHE-
NOTYPE-to-Gene summaries. Table 8 consists of
selected mouse phenotypes which fall into similar gen-
eral classes of the human table 7 followed by 6 repre-
sentative genes that have been assigned to the
appropriate phenotypic term due to a specific mouse
genetic model. Unlike the human Disease/Phenotype-to-
Table 3 Selected Major Genes and Disease Phenotypes
Gene Gene
APOE ALZHEIMER DISEASE (70) VDR PROSTATIC NEOPLASMS (10)
CORONARY DISEASE (8) OSTEOPOROSIS, POSTMENOPAUSAL (8)
CARDIOVASCULAR DISEASES (7) BREAST NEOPLASMS (7)
MYOCARDIAL INFARCTION (6) DIABETES MELLITUS, TYPE 1 (6)
DIABETES MELLITUS, TYPE 2 (6) OSTEOPOROSIS (6)
ACE HYPERTENSION (47) MTHFR NEURAL TUBE DEFECTS (6)
DIABETES MELLITUS, TYPE 2 (25) COLORECTAL NEOPLASMS (5)
MYOCARDIAL INFARCTION (17) DIABETES MELLITUS, TYPE 2 (5)
CORONARY DISEASE (16) ESOPHAGEAL NEOPLASMS (5)
DIABETIC NEPHROPATHIES (15) ADENOCARCINOMA (4)
HLA-DQB1 DIABETES MELLITUS, TYPE 1 (30) CYP17A1 BREAST NEOPLASMS (10)
PAPILLOMAVIRUS INFECTIONS (7) PROSTATIC NEOPLASMS (9)
CELIAC DISEASE (6) PROSTATIC HYPERPLASIA (4)
AUTOIMMUNE DISEASES (5) OSTEOPOROSIS, POSTMENOPAUSAL (3)
TUBERCULOSIS, PULMONARY (5) ENDOMETRIAL NEOPLASMS (2)
DRD2 ALCOHOLISM (17) ADRB2 ASTHMA (12)
SCHIZOPHRENIA (14) OBESITY (10)
PERSONALITY DISORDER (2) HYPERTENSION (8)
DEPRESSIVE DISORDER (2) DIABETES MELLITUS, TYPE 2 (4)
DYSKINESIA, DRUG INDUCED (2) BRONCHIAL HYPERREACTIVITY (4)
PPARG DIABETES MELLITUS, TYPE 2 (18) NOS3 HYPERTENSION (20)
OBESITY (11) MYOCARDIAL INFARCTION (18)
DIABETES MELLITUS (6) CORONARY ARTERY DISEASE (15)
INSULIN RESISTANCE (4) CORONARY DISEASE (12)
GLUCOSE INTOLERANCE (2) DIABETES MELLITUS, TYPE 2 (10)
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Gene
ID
HUGO Gene
Sym.
MESH TERM 1 MESH TERM 2 MESH TERM 3 MESH TERM 4
348 APOE Alzheimer Disease(70) Coronary Disease(8) Cardiovascular Diseases(7) Diabetes Mellitus, Type 2(6)
1636 ACE Hypertension(47) Diabetes Mellitus, Type 2
(25)
Myocardial Infarction(17) Coronary Disease(16)
3119 HLA-DQB1 Diabetes Mellitus, Type 1(30) Papillomavirus Infections
(7)
Celiac Disease(6) Tuberculosis, Pulmonary(5)
1493 CTLA4 Diabetes Mellitus, Type 1(28) Graves Disease(21) Thyroiditis, Autoimmune(10) Autoimmune Diseases(8)
183 AGT Hypertension(24) Coronary Disease(6) Diabetic Nephropathies(5) Myocardial Infarction(5)
1814 DRD3 Schizophrenia(24) Dyskinesia, Drug-Induced
(6)
Psychotic Disorders(5) Alcoholism(2)
4846 NOS3 Hypertension(20) Myocardial Infarction(18) Coronary Artery Disease(15) Coronary Disease(12)
3075 CFH Macular Degeneration(19) Choroidal
Neovascularization(3)
Hemolytic-Uremic
Syndrome(2)
Atrophy(2)
3077 HFE Hemochromatosis(18) Cardiovascular Diseases(1) Colorectal Neoplasms(1) Liver Cirrhosis(1)
3356 HTR2A Schizophrenia(18) Alzheimer Disease(4) Depressive Disorder(4) Depressive Disorder, Major(4)
1585 CYP11B2 Hypertension(18) Cardiovascular Diseases(2) Ventricular Dysfunction, Left
(2)
Cardiomyopathy, Dilated(2)
5468 PPARG Diabetes Mellitus, Type 2(18) Obesity(11) Diabetes Mellitus(6) Insulin Resistance(4)
2784 GNB3 Hypertension(18) Insulin Resistance(4) Diabetes Mellitus, Type 2(3) Obesity(3)
1815 DRD4 Attention Def. Dis. with
Hyperact. (17)
Schizophrenia(8) Substance-Related Disorders
(4)
Mood Disorders(4)
1813 DRD2 Alcoholism(17) Schizophrenia(14) Personality Disorders(2) Depressive Disorder(2)
155 ADRB3 Obesity(17) Diabetes Mellitus, Type 2
(9)
Insulin Resistance(6) Endometrial Neoplasms(2)
9370 ADIPOQ Diabetes Mellitus, Type 2(17) Insulin Resistance(11) Obesity(8) Hypertension(4)
3123 HLA-DRB1 Arthritis, Rheumatoid(16) Diabetes Mellitus, Type 1
(16)
Multiple Sclerosis(8) Lupus Erythematosus,
Systemic(7)
118 ADD1 Hypertension(16) Cardiovascular Diseases(3) Cerebral Hemorrhage(1) Diabetic Angiopathies(1)
3117 HLA-DQA1 Diabetes Mellitus, Type 1(15) Graves Disease(4) Autoimmune Diseases(4) Celiac Disease(4)
1956 EGFR Lung Neoplasms(15) Carcinoma, Non-SC Lung
(10)
Adenocarcinoma(6) Neoplasm Recurrence, Local
(3)
6690 SPINK1 Pancreatitis(15) Chronic Disease(11) Acute Disease(3) Pancreatitis, Alcoholic(3)
6934 TCF7L2 Diabetes Mellitus, Type 2(15) Insulin Resistance(4) Diabetes Mellitus(2) Liver Neoplasms(1)
1234 CCR5 HIV Infections(14) Diabetes Mellitus, Type 2
(4)
Diabetic Nephropathies(4) Asthma(3)
5663 PSEN1 Alzheimer Disease(14) Down Syndrome(2) Dementia(1) Cerebral Amyloid
Angiopathy(1)
11132 CAPN10 Diabetes Mellitus, Type 2(14) Insulin Resistance(3) Polycystic Ovary Syndrome
(2)
Obesity(2)
3553 IL1B Stomach Neoplasms(14) Helicobacter Infections(6) Alzheimer Disease(5) Periodontitis(3)
6532 SLC6A4 Depressive Disorder, Major(13) Depressive Disorder(13) Bipolar Disorder(10) Alcoholism(8)
4210 MEFV Familial Mediterranean Fever
(13)
Amyloidosis(4) Behcet Syndrome(3) Colitis, Ulcerative(2)
3172 HNF4A Diabetes Mellitus, Type 2(13) Glucose Intolerance(2) Birth Weight(1) Fetal Macrosomia(1)
7157 TP53 Carcinoma, Squamous Cell(13) Lung Neoplasms(12) Breast Neoplasms(10) Carcinoma, Non-SC Lung(9)
672 BRCA1 Breast Neoplasms(12) Ovarian Neoplasms(5) Carcinoma, Endometrioid(1) DNA Damage(1)
185 AGTR1 Hypertension(12) Myocardial Infarction(3) Coronary Disease(3) Pregnancy Comp.,
Cardiovascular(2)
154 ADRB2 Asthma(12) Obesity(10) Hypertension(8) Diabetes Mellitus, Type 2(4)
3953 LEPR Obesity(12) Body Weight(4) Insulin Resistance(4) Glucose Intolerance(3)
2169 FABP2 Diabetes Mellitus, Type 2(12) Insulin Resistance(10) Obesity(7) Hyperlipidemias(4)
929 CD14 Asthma(12) Myocardial Infarction(5) Arteriosclerosis(4) Colitis, Ulcerative(4)
26191 PTPN22 Arthritis, Rheumatoid(11) Diabetes Mellitus, Type 1
(9)
Lupus Erythematosus,
Systemic(5)
Arthritis, Psoriatic(2)
3596 IL13 Asthma(11) Hypersensitivity,
Immediate(4)
Pulmonary Dis., Chronic
Obstr. (4)
Respiratory Hypersensitivity
(2)
1080 CFTR Cystic Fibrosis(10) Pancreatitis(5) Chronic Disease(3) Acute Disease(2)
Zhang et al. BMC Medical Genomics 2010, 3:1
http://www.biomedcentral.com/1755-8794/3/1
Page 7 of 22Table 5 Selected Mouse Genes-Disease Phenotypes
Mouse
Gene Sym.
Human
Ortholog Gene
Sym.
Mouse
Phenotype 1
Mouse Phenotype 2 Mouse Phenotype 3 Mouse Phenotype
4
Mouse Phenotype 5
A4galt A4GALT abnormal induced
morb./mort.
abnormal resp./metab.
to xenobiotics
life span-post-
weaning/aging
homeostasis/metab.
phenotype
Abca2 ABCA2 tremors decreased body
weight
behavior/neurological
phenotype
hyperactivity increased startle reflex
Abcc2 ABCC2 abnormal blood
chemistry
abnormal liver
physiology
abnormal urine
chemistry
abnormal kidney
physiology
Abn. resp./metabolism
to xenobiotics
Abi2 ABI2 abn. corpus
callosum morph.
abnormal cerebral
cortex morph.
abnormal
hippocampus morph.
abnormal dentate
gyrus morph.
microphthalmia
Acaca ACACA abnormal liver
physiology
abnormal lipid level incr. circulating free
fatty acid level
hyperglycemia embryonic growth
arrest
Acads ACADS hypoglycemia behavior/neurological
phenotype
abnormal drinking
behavior
abnormal food
preference
abnormal urine
chemistry
Accn1 ACCN1 retinal
degeneration
vision/eye phenotype abnormal eye
electrophysiology
Adad1 ADAD1 impaired
fertilization
male infertility asthenozoospermia oligozoospermia reproductive system
phenotype
Adam23 ADAM23 tremors behavior/neurological
phenotype
ataxia postnatal lethality lethality-postnatal
Adarb1 ADARB1 behavior/
neurological
phenot.
seizures postnatal lethality behavior/
neurological
phenotype
normal phenotype
Adipoq ADIPOQ vasculature
congestion
increased body
weight
decreased body
weight
abnormal CNS syn.
transmission
abnormal coat
appearance
Adora1 ADORA1 behavior/
neurological
phenot.
increased anxiety-
related response
abnormal body
temperature regulation
abnormal
angiogenesis
abnormal nervous
system electrophys.
Ager AGER increased bone
density
abnormal cancellous
bone morph.
abnormal blood
chemistry
reproductive system
phenotype
abnormal cell
proliferation
Akap1 AKAP1 reduced female
fertility
decreased litter size abnormal female
meiosis
increased
cholesterol level
Apoc1 APOC1 abnormal circ.
cholesterol level
abnormal lipid level increased circulating
triglyceride level
abnormal immune
sys. Morph.
abnormal bile
composition
B2m B2M decreased
hematocrit
abnormal interleukin-
10 physiology
rectal prolapse abnormal dorsal
root gang. morph.
enlarged spleen
Bax BAX enlarged spleen increased thymocyte
number
abnormal motor
neuron morph.
short snout abnormal sympathetic
neuron morph.
Bcl2 BCL2 small ears absent melanin
granules in hair follicle
abnormal snout
morph.
herniated abdominal
wall
abnormal small
intestine morph.
Bmp1 BMP1 abnormal heart
morph.
abnormal aorta
morph.
abnormal ventricular
septum morph.
abnormal awl hair prenatal lethality
Brca1 BRCA1 abnormal cell
death
increased cell
proliferation
decreased cell
proliferation
decreased anxiety-
related resp.
kinked tail
Capn10 CAPN10 abnormal pancreas
physiology
endocrine/exocrine
gland phenotype
digestive/alimentary
phenotype
decreased
inflammatory
response
Casp1 CASP1 abnormal
apoptosis
abnormal induced
morbidity/mortality
abnormal
inflammatory response
decr. suscep. to
endotoxin shock
tumorigenesis
Ccr4 CCR4 immune system
phenotype
decreased tumor
necrosis factor secr.
decreased interleukin-1
beta secretion
abnormal induced
morbid./mort.
Dusp1 DUSP1 thick alveolar
septum
abnormal circ. alanine
transaminase
hypotension increased thymocyte
number
lung inflammation
E2f1 E2F1 abnormal cell
death
decreased salivation enlarged thymus pale liver exencephaly
Epo EPO abnormal
erythropoiesis
abnormal pericardium
morph.
small liver postnatal growth
retardation
abnormal hepatocyte
morph.
Ercc4 ERCC4 abnormal cell
content/morph.
abnormal liver morph. decreased body
weight
absent blood islands liver/biliary system
phenotype
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Page 8 of 22gene tables 7 and S4, the mouse tables 8 and S5 do not
have quantitative information. Table 8 is also a small
representative set, truncated in the number of disease
phenotypes (rows) and the number of genes (columns).
The complete list of 5,142 mouse phenotype terms with
their corresponding Mammalian PhenoCode designa-
tions can be found in Table S5a[39]. An interactive ver-
sion of the complete list can be found in Table S5b[40].
Using disease and gene lists
The purpose of this project is not simply to generate
lists and information. It is to provide a distillation of
disease and phenotype information that can be used in
dissecting the complexities of human disease and mouse
biology. Now that we have generated GENE-to-disease/
phenotype summaries and DISEASE/PHENOTYPE-to-
gene summaries for both mouse and human, they can
be used for systematic analysis, comparison, and inte-
grating of orthologous data with the goal of providing
higher order interpretations of human disease and
mouse genetically determined phenotypes.
Human disease and mouse phenotype based gene sets
Gene sets have been defined simply as groups of genes
that share common biological function, chromosomal
location, or regulation[41]. Gene sets are used in high-
throughput systematic analysis of microarray data using
ap r i o r ik n o w l e d g e .U n l i k ep reviously defined gene sets
based on biological pathways or differentially expressed
genes[41], GAD disease gene sets are unique in that
they are composed of genes that have been previously
shown to be both polymorphic and have been deter-
mined to be genetically positively associated with a spe-
cific disease phenotype in a human population based
genetic association study. Similarly, Table S5a[39] the
mouse DISEASE/PHENOTYPE-to-Gene list is used as a
source for gene sets for mouse phenotypes (MP gene
sets) comprised of unique gene based mouse genetic
models. These gene set files are currently the largest set
of gene set files publicly available and the only gene sets
files where each gene is based on direct human or
mouse genetic studies.
Comparison of individual GAD disease gene sets
One aspect of common complex disease is that the devel-
opment of disease and disease phenotypes quite often
present along a broad spectrum of symptoms and share
clinical characteristics, endo-phenotypes, or quantitative
traits with closely related disorders [25]. This is evident
in gene sharing, as mentioned above, and equally in the
overlap of biological pathways between related disorders.
Using GAD disease gene sets, Venn diagram comparisons
among related disorders shows modest gene sharing.
However, when gene sets are then placed into biological
pathways and compared by Venn analysis, there is a
Table 5: Selected Mouse Genes-Disease Phenotypes (Continued)
F5 F5 behavior/
neurological
phenot.
abnormal somite
development
abnormal yolk sac
morph.
increased suscep. to
bact. Infect.
hemorrhage
Fcgr1 FCGR1A impaired
macrophage
phagocyt.
abnormal
inflammatory response
decreased
inflammatory response
abnormal yolk sac
morph.
abnormal cell-
mediated immunity
Foxo1 FOXO1 absent organized
vascular net.
abnormal looping
morphogenesis
abnormal vasculature exencephaly absent vitelline blood
vessels
Gadd45a GADD45A decreased
leukocyte cell
num.
increased cell
proliferation
increased thymocyte
number
postnatal lethality skin irradiation
sensitivity
Gap43 GAP43 decreased body
weight
abnormal optic nerve
innervation
absent optic tract abnormal
erythropoiesis
nervous system
phenotype
Gata1 GATA1 decreased
hematocrit
abnormal
thrombopoiesis
extramedullary
hematopoiesis
overexpanded resp.
alveoli
liver hypoplasia
Grin1 GRIN1 abn. trigeminal
nerve morph.
atelectasis lung hemorrhage abnormal tympanic
ring morph.
decreased body
weight
Hoxa1 HOXA1 small ears abnormal inner ear
morph.
abnormal malleus
morph.
increased
susceptibility to
injury
abnormal cochlea
morph.
Hspa1a HSPA1A decreased body
weight
increased cell. Sens. to
gamma-irrad.
chromosome breakage increased body
weight
homeostasis/
metabolism
phenotype
Icam1 ICAM1 increased
leukocyte cell
number
increased neutrophil
cell number
increased monocyte
cell number
abnormal spatial
learning
abnormal retina
morph.
Igbp1 IGBP1 decreased
thymocyte number
behavior/neurological
phenotype
abnormal cued
conditioning behavior
intestinal ulcer abnormal thymus
lobule morph.
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Mouse Gene
Sym
Human Gene
Sym
Human Gene ID
#
Human Disease MeshTerm Mouse Phenotype Term
Npc1l1 NPC1L1 29881 Hypercholesterolemia(1) abnormal circulating LDL cholesterol level;
decreased circulating HDL cholesterol level;
abnormal triglyceride level;
abnormal lipid homeostasis; ...
Nkx2-5 NKX2-5 1482 Heart Defects, Congenital(1),
Heart Block(1)
abnormal heart development;
abnormal looping morphogenesis;
abnormal heart tube morphology;
abnormal heart shape;
thin ventricular wall; ...
Oprm1 OPRM1 4988 Alcoholism(9),
Substance-Related Disorders(5),
Heroin Dependence(2), Pain,
Postoperative(2),
Epilepsy, Generalized(1),
Substance Withdrawal Syndrome(1),
Cocaine-Related Disorders(1),
Diabetes Mellitus, Type 2(1),
Kidney Failure, Chronic(1),
Pain(1), Ischemia(1),
Opioid-Related Disorders(1),
Postoperative Nausea and Vomiting
(1)
abnormal response to addictive substance;
preference for addictive substance;
abnormal touch/nociception;
abnormal pain threshold;
decreased chemically-elicited antinociception;
sensitivity to addictive substance;
excitatory postsyn. potential;
resistance to addictive substance;
altered response to anesthetics; ...
Homer1 HOMER1 9456 Cocaine-Related Disorders(1) cocaine preference;
abnormal conditioning behavior;
abnormal response to addictive substance;
nervous system phenotype;
abnormal nervous system physiology;
behavior/neurological phenotype, ...
Insl3 INSL3 3640 Cryptorchidism(3),
Abnormalities, Multiple(1),
Hypospadias(1),
Gonadal Dysgenesis(1),
Infertility, Male(1),
Testicular Diseases(1)
abnormal male reproductive anatomy;
small testis;
abnormal spermatogenesis;
behavior/neurological phenotype;
male infertility;
female infertility;
abnormal estrous cycle;
abnormal gametogenesis;
decreased germ cell number;
cryptorchism; ...
Stat6 STAT6 6778 Asthma(3),
Hypersensitivity(3),
Dermatitis, Atopic(2),
Anaphylaxis(2),
Nut Hypersensitivity(1),
Nephrotic Syndrome(1),
Infertility(1),
Hypersensitivity, Immediate(1),
Graves Disease(1),
Endometriosis(1), ...
abnormal humoral immune response;
decreased IgM level;
decreased IgA level;
decreased susceptibility to viral infection;
decreased IgE level;
increased IgG level;
increased IgA level;
abnormal interleukin physiology;
abnormal interferon physiology;
abnormal CD8-positive T cell morphology; ...
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En2 EN2 2020 Autistic Disorder(1),
Asperger Syndrome(1)
abnormal social investigation;
abnormal spatial learning;
abnormal social/conspecific interaction;
abnormal cerebellum morphology;
abnormal cerebellar foliation;
abnormal vermis morphology;
abnormal cerebellar granule layer;
abnormal colliculi morphology;
hyperactivity;
impaired coordination;
abnormal grooming behavior; ...
Hsd11b1 HSD11B1 3290 Diabetes Mellitus, Type 2(2),
Obesity(2),
Hypertension(2),
Insulin Resistance(2),
Polycystic Ovary Syndrome(1),
Hyperandrogenism(1)
abnormal abdominal fat pads;
abnormal circulating cholesterol level;
decreased circulating LDL cholesterol level;
enlarged adrenal glands;
increased circulating HDL cholesterol level;
abnormal glucose homeostasis;
decreased circulating triglyceride level;
abnormal corticosterone level;
improved glucose tolerance; ...
Msh3 MSH3 4437 Lung Neoplasms(1),
Head and Neck Neoplasms(1),
Colonic Neoplasms(1),
Carcinoma, Squamous Cell(1),
Carcinoma, Small Cell(1)
tumorigenesis;
increased tumor incidence;
premature death;
life span-post-weaning/aging
Crb1 CRB1 23418 Optic Atrophies, Hereditary(1),
Blindness(1)
abnormal retinal photoreceptor morphology;
abnormal retina morphology;
retinal degeneration;
decreased retinal photoreceptor cell number;
photosensitivity;
abnormal ocular fundus morphology;
nervous system phenotype;
abnormal retinal photoreceptor layer;
abnormal photoreceptor inner segment morph;
...
Chrna7 CHRNA7 1139 Schizophrenia(3),
Auditory Perceptual Disorders(1),
Memory Disorders(1)
pharmacologically induced seizures;
decreased anxiety-related response;
abnormal spatial learning;
abnormal hippocampus function;
abnormal tumor necrosis factor physiology;
homeostasis/metabolism phenotype
Inha INHA 3623 Ovarian Failure, Premature(2),
Amenorrhea(1)
kyphoscoliosis;
abnormal liver morphology;
abnormal ovarian follicle morphology;
enlarged testes;
abnormal spermatogenesis;
increased circulating follicle stimulating
hormone;
male infertility;
female infertility;
tumorigenesis;
ovary hemorrhage;
cachexia;
diffuse hepatic necrosis;
pancytopenia;
liver/biliary system phenotype; ...
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Page 11 of 22marked increase in the overlap in pathways between
related disorders. This was not found in gene sets from
unrelated disorders. For example, major autoimmune dis-
orders quite often share endophenotypes of lymphoproli-
feration, autoantibody production, and alterations in
apoptosis, as well as other immune cellular and biochem-
ical aberrations. As shown in Figure 1a, genes that have
been positively associated with type 1 diabetes, rheuma-
toid arthritis, and Crohn’s disease show a modest overlap.
However, when individual gene sets are fitted into biolo-
gical pathways, then compared for overlap of pathway
membership, there is a striking increase in the overlap at
the pathway level. This is true in a comparison of gene
and pathways for type 2 diabetes, insulin resistance, and
obesity as well (Figure 1b). This pattern of major pathway
overlap does not seem to occur between unrelated disor-
ders, such as insulin resistance, rheumatoid arthritis and
bipolar disorder (Figure 1c). This disease related sharing
at the pathway level suggests common regulatory
mechanisms between these disorders and that the origi-
nal positive associations are not necessarily due to ran-
dom chance alone.
Group analysis of GAD disease gene sets between major
classes of disease/phenotypes
Dendrogram analysis of human disease gene sets
As archival information grows, analysis of complex
molecular and genetic datasets using clustering or net-
w o r ka p p r o a c h e sh a sb e c o m ei n c r e a s i n g l ym o r eu s e f u l
[13,42-45]. Therefore, in addition to comparisons
between individual diseases using human and mouse
gene sets, we analyzed large gene groups using dendro-
gram and clustering approaches based on gene sharing
between gene sets. Figure 2 shows a broad based den-
drogram comparison based on gene sharing between
480 GAD disease gene sets, using gene sets each con-
taining at least 3 genes. A striking feature of this analy-
sis is that at a coarse level, major disease groups cluster
together in space demonstrating shared genes between
major clinically important disease groups. Disease
domains are represented by groups such as cardiovascu-
lar disorders, metabolic disorders, cancer, immune and
inflammatory disorders, vision, and chemical depen-
dency. At finer detail within a specific broader group, it
becomes clear that individual diseases with overlapping
Table 6: Selected Human-Mouse Phenotype Overlap (Continued)
Slc6a3 SLC6A3 6531 Attention Deficit Disorder w/Hyp.(7),
Tobacco Use Disorder(3),
Schizophrenia(2),
Alcohol Withdrawal Delirium(2),
Eating Disorders(1),
Substance Withdrawal Syndrome(1),
Stress Disorders, Post-Traumatic(1),
Child Behavior Disorders(1),
Bulimia(1),
Alcoholism(1),
abnormal maternal nurturing;
hyperactivity; hypoactivity;
impaired coordination;
increased exploration in new environment;
decreased exploration in new environment;
abnormal spatial learning;
abnormal pituitary secretion;
abnormal lactation;
increased dopamine level;
cocaine preference; ...
Cyp11b2 CYP11B2 1585 Hypertension(18),
Cardiovascular Diseases(2),
Ventricular Dysfunction, Left(2),
Cardiomyopathy, Dilated(2),
Arteriosclerosis(1),
Acromegaly(1),
Fibrosis(1),
Arthritis, Rheumatoid(1),
Polycystic Ovary Syndrome(1),
Metabolic Syndrome X(1),
decreased body size;
hypotension;
increased circulating corticosterone level;
decreased circulating aldosterone level;
decreased circulating chloride level;
increased circulating renin level;
abnormal enzyme/coenzyme level;
lethality-postnatal;
homeostasis/metabolism phenotype;
growth/size phenotype; ...
Ptpn22 PTPN22 26191 Arthritis, Rheumatoid(11),
Diabetes Mellitus, Type 1(9),
Lupus Erythematosus, Systemic(5),
Arthritis, Psoriatic(2),
Autoimmune Diseases(2),
Arthritis, Juvenile Rheumatoid(2),
Nephritis(1),
Multiple Sclerosis(1),
Asthma(1),
Cholangitis, Sclerosing(1),
enlarged spleen;
enlarged lymph nodes;
abnormal Peyer’s patch germinal center morph;
abnormal T cell physiology;
increased IgE level;
increased B cell number;
immune system phenotype;
hematopoietic system phenotype;
increased follicular B cell number;
increased spleen germinal center number;
increased IgG1 level;
increased IgG2a level; ...
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Disease Mesh Term Gene
Rank 1
Gene
Rank 2
Gene Rank
3
Gene
Rank 4
Gene
Rank 5
Gene Rank
6
Gene
Rank 7
Gene
Rank 8
DISEASE CLASS - CARDIOVASCULAR
Hypertension ACE(47) AGT(24) NOS3(20) CYP11B2
(18)
GNB3(18) ADD1(16) AGTR1(12) ADRB2(8)
Myocardial Infarction NOS3(18) ACE(17) SERPINE1
(11)
ITGA2(7) LPL(6) APOE(6) GP1BA(5) F7(5)
Coronary Disease ACE(16) NOS3(12) PON1(11) APOB(11) APOE(8) LPL(7) AGT(6) SERPINE1
(6)
Coronary Artery Disease NOS3(15) PON1(9) ACE(7) APOA5(6) APOE(5) AGT(4) ABCA1(4) APOA1(4)
Hypertrophy, Left Ventricular ACE(15) GNB3(3) AGTR2(2) EDN1(2) TNNT2(2) NOS3(2) ENPP1(1) ACE2(1)
Venous Thrombosis F5(8) F2(5) SERPINE1(4) MTHFR(3) ABO(2) F8(2) JAK2(2) PROCR(2)
Cardiovascular Diseases APOE(7) CETP(6) ACE(5) NOS3(5) PON1(4) APOA5(4) APOC3(4) SERPINE1
(3)
Myocardial Ischemia ACE(6) LPL(5) NOS3(2) ITGB3(2) APOB(2) AGT(1) AGTR1(1) SELPLG(1)
Arteriosclerosis ACE(5) CD14(4) PON1(3) FGB(3) MTHFR(3) NOS3(3) APOE(3) TLR4(2)
Cardiomyopathies TTR(5) HFE(1) APOA1(1) HLADQB1
(1)
SOD2(1) CCR2(1) SELE(1) MMP9(1)
Heart Failure ADRA2C(5) ADRB1(5) ACE(3) NOS3(3) ADRB2(3) AMPD1(2) SCNN1B(1) EDN1(1)
DISEASE CLASS - DIGESTIVE SYS.
DISEASES
Pancreatitis SPINK1(15) CFTR(5) PRSS1(3) HLA-DRB1
(2)
HLA-A(1) TLR4(1) UGT1A7(1) KRT8(1)
Cystic Fibrosis CFTR(10) NOS1(2) SERPINA1
(2)
SPINK1(1) CAPN10(1) SFTPA2(1) GCLC(1) FCGR2A(1)
Celiac Disease HLADQB1
(6)
CTLA4(6) HLADQA1
(4)
TNF(2) PTPN22(1) IFNG(1) TIPARP(1) IL21(1)
Crohn Disease IL23R(6) NOD2(5) TNF(5) ABCB1(4) CD14(4) IBD5(3) DLG5(3) MIF(3)
Liver Cirrhosis, Alcoholic ALDH2(6) ACE(1) TNF(1) SOD2(1) ADH1C(1) ADH1B(1) DRD2(1) CYP2E1(1)
Colitis, Ulcerative ABCB1(5) IL23R(5) TNF(4) CD14(4) TLR4(3) ICAM1(3) IL1RN(3) CTLA4(3)
Gastritis, Atrophic MPO(3) TLR4(1) IL13(1) PTPN11(1) TNF(1) ABO(1) CMA1(1) IL1B(1)
Inflammatory Bowel Diseases TNF(3) ABCB1(3) IL23R(3) ITPA(2) NOD2(2) DLG5(2) HP(2) PON1(1)
Cholangitis, Sclerosing HLADRB1
(2)
HP(2) PTPN22(1) MMP1(1) HLADQA1
(1)
TNF(1) HLADQB1
(1)
MMP3(1)
DISEASE CLASS - DIS. OF
ENVIRONMENTAL ORIGIN
Alcoholism DRD2(17) OPRM1(9) SLC6A4(8) ALDH2(7) MAOA(6) GABRA2(4) NPY(4) ADH1B(3)
DNA Damage XRCC1(7) TP53(3) CYP1A1(3) GSTM1(3) OGG1(3) LIG4(2) APEX1(2) BRCA2(2)
Substance-Related Disorders SLC6A4(5) OPRM1(5) DRD4(4) DRD5(2) BDNF(2) ADH4(2) CNR1(2) DRD2(2)
Fractures, Bone ESR1(4) ESR2(2) COL1A1(2) CYP19A1(1) IGF1(1) TNFRSF11B
(1)
P2RX7(1) TGFB1(1)
Tobacco Use Disorder CYP2A6(3) SLC6A3(3) CHRNA4(2) TH(2) BDNF(1) PPP1R1B(1) SLC18A2(1) PTEN(1)
Cocaine-Related Disorders PDYN(2) HOMER1(1) TTC12(1) ANKK1(1) DBH(1) GSTP1(1) OPRM1(1)
Heroin Dependence OPRM1(2) BDNF(1) OPRD1(1) SLC6A4(1) COMT(1) MAOA(1)
Spinal Fractures COL1A1(2) CYP19A1(1) TNFRSF11B
(1)
GC(1) PLXNA2(1) AR(1) NOS3(1)
DISEASE CLASS - IMMUNE SYSTEM
Autoimmune Diseases CTLA4(8) HLADQB1
(5)
HLADRB1(4) HLADQA1
(4)
PTPN22(2) HLA-A(2) CYP2D6(2) CIITA(2)
Hypersensitivity, Immediate IL4R(8) IL13(4) CD14(4) IL4(2) SERPINE1
(2)
CCL5(2) NOS2A(2) CTLA4(2)
Graft vs Host Disease IFNG(3) TNF(2) TLR4(1) NOD2(1) HLA-DPB1
(1)
HLA-A(1) IL10(1) IL1R1(1)
Hypersensitivity IL4(3) STAT6(3) IL4R(2) IFNG(1) IFNGR1(1) TLR2(1) FADS1(1) IL13(1)
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Antiphospholipid Syndrome F2(2) SELPLG(1) SERPINE1(1) FCGR2A(1) HLADMA(1)
Food Hypersensitivity IL4(1) IL4R(1) STAT6(1) IL13(1) HLADQB1
(1)
CD14(1)
DISEASE CLASS - MENTAL DISORDERS
Schizophrenia DRD3(24) HTR2A(18) DRD2(14) COMT(10) HTR2C(8) BDNF(8) DRD4(8) NOTCH4(8)
Attention Deficit Disorder with
Hyperactivity
DRD4(17) SLC6A3(7) SLC6A4(6) ADRA2A(4) MAOA(3) SNAP25(3) SLC6A2(2) DRD5(2)
Depressive Disorder SLC6A4(13) HTR2A(4) TPH1(3) CYP2D6(2) CYP2C19(2) MAOA(2) BDNF(2) DRD2(2)
Depressive Disorder, Major SLC6A4(13) TPH1(5) HTR2A(4) TPH2(3) BDNF(2) DRD2(2) GNB3(2) DTNBP1(1)
Bipolar Disorder SLC6A4(10) BDNF(6) MAOA(5) COMT(5) XBP1(3) GABRA5(3) HTR2A(3) TPH2(3)
Anxiety Disorders SLC6A4(7) MAOA(3) PLXNA2(1) BDNF(1) DBI(1) MED12(1) GABRB3(1) DRD2(1)
Mood Disorders SLC6A4(5) DRD4(4) CLOCK(2) MAOA(2) BDNF(2) ACE(1) CRH(1) DRD3(1)
Psychotic Disorders DRD3(5) SLC6A4(3) DRD4(3) HTR2A(3) DTNBP1(2) DISC1(2) DRD2(2) MAOA(1)
Obsessive-Compulsive Disorder SLC6A4(4) HTR2A(3) COMT(3) SLC1A1(2) DRD4(2) HTR1B(1) BDNF(1) NRCAM(1)
Panic Disorder CCK(4) HTR1A(2) MAOA(2) HTR2A(2) DBI(1) CCKAR(1) ADORA2A
(1)
PGR(1)
Cognition Disorders APOE(3) BDNF(3) DRD4(2) COMT(2) HMGCR(1) DTNBP1(1) SLC6A4(1) NQO1(1)
DISEASE CLASS - NERVOUS SYSTEM
DISEASES
Alzheimer Disease APOE(70) PSEN1(14) A2M(10) CYP46A1(8) ACE(7) BCHE(7) IL1A(7) BDNF(6)
Parkinson Disease PARK2(9) LRRK2(9) CYP2D6(7) MAOB(7) BDNF(5) SNCA(5) PON1(4) PINK1(4)
Multiple Sclerosis HLADRB1
(8)
APOE(5) CTLA4(4) PTPRC(4) MBP(3) HLA-DQB1
(3)
IFNG(2) CRYAB(2)
Amyotrophic Lateral Sclerosis SOD1(6) PON1(2) PON2(2) VEGFA(2) SMN1(1) MAPT(1) MT-ND5(1) PON3(1)
Brain Ischemia FGB(5) PDE4D(3) NOS3(3) ACE(2) PON1(2) MTHFR(2) ITGB3(2) TLR4(1)
Cerebrovascular Accident NOS3(5) APOE(5) FGB(5) PON1(4) SERPINE1
(3)
ALOX5AP
(3)
ACE(2) KL(2)
Carotid Artery Diseases NOS3(4) PON1(3) MTHFR(3) CCL2(2) IL6(2) APOE(2) CD14(2) ACE(1)
Dementia APOE(4) MAPT(3) MT-ND1(1) PRNP(1) PSEN1(1) TNF(1) CDC2(1) IGF1R(1)
DISEASE CLASS - NUTR. AND
METABOLIC DISEASES
Diabetes Mellitus, Type 2 ACE(25) PPARG(18) ADIPOQ(17) TCF7L2(15) CAPN10
(14)
HNF4A(13) FABP2(12) NOS3(10)
Obesity ADRB3(17) LEPR(12) MC4R(11) PPARG(11) UCP2(11) ADRB2(10) UCP1(8) ADIPOQ(8)
Insulin Resistance ADIPOQ
(11)
FABP2(10) INSR(7) IRS1(7) ENPP1(7) ADRB3(6) NOS3(6) ACE(5)
Diabetes Mellitus PPARG(6) ACE(3) INS(3) NOS3(3) PON1(2) UBL5(2) IRS1(2) TCF7L2(2)
Hyperlipidemias APOA5(5) FABP2(4) LPL(3) APOE(3) ACE(2) APOA1(2) PPARA(2) PPARG(2)
Hypertriglyceridemia APOC3(5) APOA5(4) LPL(3) APOE(3) ADRB2(2) APOA4(2) GP1BA(1) LTA(1)
Glucose Intolerance LEPR(3) ADIPOQ(3) IGF1(2) KCNJ11(2) PTPN1(2) PPARG(2) HNF4A(2) NEUROG3
(1)
Hypercholesterolemia APOA1(3) APOB(3) F12(3) ACE(2) LDLR(2) LPL(2) PCSK9(2) ABCG8(2)
Metabolic Syndrome APOC3(3) UBL5(2) NOS3(2) ACE(1) PPARD(1) NPY5R(1) ACE2(1) RGS2(1)
DISEASE CLASS - EYE DISEASES
Macular Degeneration CFH(19) APOE(4) PON1(2) C2(1) CFB(1) ABCA1(1) HTRA1(1) MELAS(1)
Diabetic Retinopathy VEGFA(7) AKR1B1(4) PON1(3) RAGE(3) AGER(3) ACE(2) ITGA2(2) ICAM1(2)
Glaucoma CYP1B1(3) OPTN(2) OPA1(2) OPTC(1) EDNRA(1) MYOC(1)
Ocular Hypertension OPTN(2) CYP1B1(1) OLFM2(1) OPA1(1)
Cataract GALT(1) AIPL1(1) IFNGR1(1) GCNT2(1)
Retinal Degeneration NDP(1) GUCA1A(1) AIPL1(1) COL2A1(1) RHO(1) GUCA1B(1) ABCA4(1)
Myopia HLADPB1
(1)
LUM(1) COL2A1(1) NYX(1) MYOC(1)
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PhenoCode PhenoType
DISEASE CLASS CARDIOVASCULAR Gene 1 Gene 2 Gene 3 Gene 4 Gene 5 Gene 6 Gene 10
MP:0005048 thrombosis Abca5 Actc1 Adamts13 Ahr Alox12 Anxa2 F2rl2
MP:0005341 decreased sus. to atherosclerosis APOA1 Apoe Artles Ath17 Ath29 Ath37 Icam1
MP:0000231 hypertension Abcc9 Ace2 Add2 Agt Alb1-Ren Bpq5 Chga
MP:0004181 abnormal carotid artery morphology Aldh1a2 Chrd Crk Ednra Fgf8 Foxm1 Shc1
MP:0004111 abnormal coronary artery morph. Adm Ahr Fgf8 Gja1 Hspg2 Itga4 Vegfa
MP:0005338 atherosclerotic lesions Aorls1 Aorls2 Apoe Ath29 Ath6 Ath8 Fabp4-
Aebp1
MP:0000343 altered resp. to myocardial infarction Agtr2 Aifm1 Ak1 Bnip3 CMV-
Abcc9
Ccr1 Ckm-
Prkaa2
MP:0006058 decreased cerebral infarction size ACTB-Ngb EGFP Adora2a Cx3cl1 F11 F12 Plat
MP:0003037 increased infarction size Aifm1 Fgf2 Hmox1 Kit Mapk1 Myh6-tTA Thbd
MP:0004875 Inc. mean arterial blood pressure Ddah1 Edn1 Ednrb Kcnn3 Ptger1 Tagln-tTA
MP:0005339 Inc. susceptibility to atherosclerosis Apoa1 Apoe Artles Ascla1 Ascla2 Ascla3 Ath18
DISEASE CLASS - DIGESTIVE SYSTEM
DISEASES
Gene 1 Gene 2 Gene 3 Gene 4 Gene 5 Gene 6 Gene 10
MP:0003119 abnormal digestive system dev. Cdkn1c Cyp26a1 Foxp4 Mapk7 Mcm4 Nckap1 Tbx6
MP:0000462 abnormal digestive system morph. Apc Bmp5 Cdcs1 Cdkn1c Cftr Ctnnbip1 Gast
MP:0001663 abnormal digestive system phys. Apoe Cd44 Cftr Clec7a Col2a1 Fut2 Gpx1
MP:0000474 abnormal foregut morphology Apc Foxa2 Gata4 Gdf1 Hgs Ldb1 Otx2
MP:0000488 abnormal intestinal epithelium morph Atr B4galt1 B9d2 Bdkrb2 Cbfa2t2 Col1a1 Elf3
MP:0003449 abnormal intestinal goblet cells Areg Cbfa2t2 Cftr Clca3 Ctnnb1 E2f4 Il13
MP:0006001 abnormal intestinal transit time Drd2 Gfra2 Gucy1b3 Hmox2 Mrvi1 Smtn
MP:0000470 abnormal stomach morphology Ahr Aire Barx1 Celsr3 Cfc1 Col1a1 Gdf11
DISEASE CLASS - DIS. OF ENVIRONMENTAL
ORIGIN
Gene 1 Gene 2 Gene 3 Gene 4 Gene 5 Gene 6 Gene 10
MP:0001425 abnormal alcohol consumption Aaq1 Alcp1 Alcp19 Alcp2 Ap7q Ap8q Ppp1r1b
MP:0005443 abnormal ethanol metabolism Adh1 Adh7 Afteq1 Afteq2 Alcw3 Htas2
MP:0002552 abnormal response to addictive sub. Adora2a Adra1d Alcw1 Alcw2 Alcw3 Alcw4 Chrna4
MP:0001987 alcohol preference Alcp1 Alcp25 Alcp3 Alcp4 Alprf Ap1q Ap5q
MP:0001988 cocaine preference Grm2 Homer1 Homer2 Per2 Slc6a3 Slc6a4
MP:0003546 decreased alcohol consumption Camk2a Gnas Gria3 Prkce tmgc55
MP:0004048 resistance to addictive substance Adora2a Adra1b Apba1 Aqp4 Btbd14b Chrna4 Slc6a3
DISEASE CLASS - IMMUNE SYSTEM
DISEASES
Gene 1 Gene 2 Gene 3 Gene 4 Gene 5 Gene 6 Gene 10
MP:0001844 autoimmune response Tcra Tcrb ACTB Aire Cd1d1 Fas Ikzf3
MP:0005016 decreased lymphocyte cell number Atm Bcl2 Bcl6b Birc2 C3ar1 Ccr9 Ctsd
MP:0008088 abnormal T-helper 1 cell diff. Cbfb Ifngr2 Il2 Il4 Irf4 Mapk8 Sit1
MP:0002499 chronic inflammation Ccr7 Gstz1 Hmox1 Il10 Il1rn Jak3 Plcg2
MP:0004804 dec. sus. to autoimmune diabetes HLA-DQA1 HLA-DQB1 Art2a B2m Cd4 Cd4DsRed Cdk4
MP:0002411 decreased sus. to bacterial infection Anth Anth2 B2m C4b Casp1 Cd97 Dcn
MP:0005597 dec. sus. to type I hypers-reaction Alox5 Alox5ap Cysltr1 Cysltr2 Fcer1a Fcer1g Orai1
MP:0003725 increased autoantibody level Tcra Tcrb Acla1 Acla2 Aire Cd276 Cia38
MP:0005014 increased B cell number BCL2 Bak1 Bax Bcl11b Bcl2l11 Bst1 Cdkn2c
MP:0005013 increased lymphocyte cell number Axl B4galt1 Bak1 Casp8 Cd19 Ewsr1 Galnt1
MP:0004803 Inc. sus. to autoimmune diabetes Ins1-Cat Tyr B2m Cd274 Cd28 Cd38 Cdk2
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Page 15 of 22Table 8: Selected Mouse Disease Related Phenotypes (Continued)
MP:0005350 Inc. sus. to autoimmune disorder Tcra Tcrb Ads1 Ads2 Ads3 Ads4 Bak1
MP:0002412 increased sus. to bacterial infection Adamts13 Adcyap1r1 Adh5 Atf2 Bbaa21 Bcl10 C3
DISEASE CLASS - MENTAL DISORDERS
DISEASE CLASS - MENTAL DISORDERS
Gene 1 Gene 2 Gene 3 Gene 4 Gene 5 Gene 6
MP:0001412 excessive scratching Atp2b4 Bdnf Ctsl EIF1AX Lck-Il31ra Mapt Gene 10
MP:0001362 abnormal anxiety-related response App Araf Axtofd1 Axtofd3 Axtofd4 Axtofd5
MP:0001458 abnormal object recognition memory Gabbr1 Gal Grin1 Prnp Prnp-App Psen1 Crhr1
MP:0001360 abnormal social investigation Avpr1a Avpr1b Cadps2 En2 Gnao1 Grin1
MP:0002557 abnormal social/conspecific int. Ar Cadps2 Disc1 En2 Grin1 Grin3b Maoa
MP:0002065 abnormal fear/anxiety-related beh. APPV717I App Atp1a2 Crebbp Egr1 Gnai1 Oxt
MP:0001364 decreased anxiety-related response APP Adcy8 Adcyap1 Adcyap1r1 Avpr1a B3galt2 Nos3
MP:0002573 behavioral despair Adra2c B3gnt2 Cacna1c Crhr2 Desp1 Desp2 Camk2a
MP:0001462 abn. avoidance learning behavior Aal Aap Dcx Idua Ntrk2 Nr3c1
DISEASE CLASS - NUTR. AND METABOLIC
DISEASES
Gene 1 Gene 2 Gene 3 Gene 4 Gene 5 Gene 6
MP:0005560 decreased circulating glucose level Ins1-Cat Tyr Acadm Adipoq Apcs-Lep Apoe Gene 10
MP:0004185 abnormal adipocyte glucose uptake Akt2 Bglap1 Cebpa Pik3r1 Prkci Ptprv Cd36
MP:0000188 abnormal circulating glucose level Adipor1 Cidea Ciita Ckm Crh Dbm3
MP:0001560 abnormal circulating insulin level Cacna1c Cebpa Foxa1 Gal Gck IGFBP2 Irs2
MP:0003383 abnormal gluconeogenesis Adipoq Adipor1 Cebpa Cebpb Lpin1 Mc2r Mgat4a
MP:0005291 abnormal glucose tolerance Adipoq Fstl3 Irs4 Lep Pcsk1 Pnpla2 Smarcb1
MP:0003564 abnormal insulin secretion Eif2ak3 Gast Gck Gjd2 Ins2 Lep
MP:0002727 decreased circulating insulin level Adcyap1r1 Adipor2 Ahsg Akt2 Apcs-Lep Apoa2
MP:0002711 decreased glucagon secretion Cacna1e Dbh Kcnj11 Nkx2-2 Pcsk2 Bglap1
MP:0003059 decreased insulin secretion Abcc8 Anxa7 Bglap1 Cacna1e Cartpt Chrm3
MP:0001548 hyperlipidemia APOC1 Acox1 Apc Apoe Cdkn1b Cpt1c Eif2s1
MP:0005293 impaired glucose tolerance APPswe PSEN1dE9 Abcc8 Acadvl Adcyap1r1 Adipoq Lepr
MP:0005292 improved glucose tolerance Adipor2 Ahsg Bcat2 Cbl Crebbp Cxcl14 Akt2
MP:0004892 increased adiponectin level Actb Adipor2 Cideb Crebbp Pde3b Pten Gcgr
MP:0002575 Inc. circulating ketone body level Acacb Adcyap1 Gck AZIP Ins2 Ins2-Nos2 Scd1
MP:0003645 Inc. pancreatic beta cell number ACTB Akt2 Arx Hnf4a Cdkn1b Foxo1 Ins2-rtTA
MP:0001759 increased urine glucose level Aqp1 Aqp7 Cdk4 Cdk4 Cryaa-TAg Dnajc3a Ins1
MP:0005331 insulin resistance APOB Adipoq Adipor1 Clcn5 Adra1b Akt2 Bglap1
DISEASE CLASS - EYE DISEASES Gene 1 Gene 2 Gene 3 Gene 4 Gene 5 Gene 6 Gene 10
MP:0001299 abnormal eye distance/position Dst Edg2 Hectd1 Hesx1 Itgb1 Nrtn
MP:0000776 abnormal inferior colliculus Atg5 En1 Ext1 Fgf17 Fgf8 Fgfr1
MP:0003236 abnormal lens capsule morphology Abi2 Cdkn2a Cryaa Cryga Hsf1 Hsf4 Otx2
MP:0002864 abnormal ocular fundus morphology Crb1 Gpr143 Mitf Pitx3 Rd9 Rp1h
MP:0002638 abnormal pupillary reflex Cat4 Cnga3 Cry1 Eccp Foxe3 Iac tmgc25
MP:0002699 abnormal vitreous body Aldh1a1 Aldh1a3 Bmp4 Cdkn2a Fzd4 Gas1
MP:0001314 corneal opacity Alm Apo Areg Bmp4 Cat4 Col4a1 Lim2
MP:0001851 eye inflammation Adam17 Atf2 Eda Fign ITGA2 ITGA5 Dsc1
MP:0005542 corneal vascularization Dstn Eda Fign Flt1 Foxe3 Ifnar1 Plg
MP:0003011 delayed dark adaptation Rbp1 Rdh11 Rdh12 Rdh5 Rdh8 Rlbp1 Pgf
MP:0005172 reduced eye pigmentation Ap3b1 Ap3d1 Hps5 Hps6 Mitf Nf1 Sema4a
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Page 16 of 22phenotypes are found close in space, such as asthma,
allergic rhinitis, and atopic dermatitis. This overlap due
to gene sharing recapitulates an overlap in clinical char-
acteristics between these related disorders. Similarly,
phenotypes within the metabolic group related to dia-
betes are closely aligned in space including; insulin resis-
tance, hyperglycemia, hyperinsulinemia, and
hyperlipidemia. This close apposition of related disease
phenotypes and sub-phenotypes at both a coarse and
fine level is a consistent feature of the overall display.
The human gene sets used in creating this tree diagram
can be found in Table S6[46]. It is important to empha-
size that this display and the distance relationships
between diseases are calculated through an unbiased
gene-sharing algorithm independent of disease pheno-
type labels and not as a result of an imposed logical
hierarchy or an ontological annotation system. This
grouping of major disease phenotypes based solely on
gene sharing provides supporting evidence that the
underlying disease based gene sets may have a funda-
mental relevance to disease and may not be reported in
the literature by chance alone.
Dendrogram analysis of mouse phenotypic gene sets
Figure 3 is a similar dendrogram to the human tree
using 1056 mouse phenotypic gene sets, using gene sets
each containing at least 10 genes. This was produced
using the same gene sharing algorithm as for the human
gene sets in Figure 2. As with the human dendrogram,
the mouse tree displays informative groupings at both a
coarse and fine level. This tree groups into major group-
ings nominally assigned as brain development and brain
function, embryonic development, cardiovascular, repro-
duction, inflammation, renal function, bone develop-
ment, metabolism, and skin/hair development. The
identification of major groupings emphasizing develop-
mental processes reflects the emphasis of gene knock-
outs and developmental models resulting in observable
morphological traits and less so with regard to end
stage clinical diseases as in the human dendrogram. Like
the human dendrogram (Figure 2) discrete major func-
tional groupings in the mouse dendrogram suggests that
individual experimental observations are not random.
Fundamental complex processes such as metabolism,
cardiovascular phenomena, and developmental processes
are integrated by extensive sharing of related pliotropic
genes. Moreover, like the human tree, fine structure in
the mouse tree shows related mouse phenotypes are clo-
sely positioned in space. For example, in the metabolism
major grouping, the individual phenotypes of body
mass, adipose phenotypes, and weight gain are closely
positioned. Similarly, in the brain function group, the
behavioral phenotypes of anxiety, exploration, and
responses to novel objects are found next to one
another. This pattern is a fundamental feature of this
tree. Like the human tree, the mouse dendrogram
shown here is based solely on a gene sharing algorithm
using genes assigned to individual phenotypes. It is not
based on an imposed predetermined hierarchy or ontol-
ogy. Importantly, unlike the human tree, the information
contained in the mouse tree is derived from individual
independent mouse genetic studies and phenotypic
observations and not from large case controlled popula-
tion based epidemiological studies. Controversial issues
such as publication bias or study size which confound
human genetic association studies are not as relevant
here in the context of studies of experimentally deter-
mined individual mouse gene knockouts and related stu-
dies. The mouse gene sets used in creating this tree
diagram can be found in Table S7[47].
Hierarchical clustering of human and mouse gene sets
Hierarchical clustering has become a common tool in
the analysis of large molecular data sets[48] allowing
identification of similar patterns in a scalable fashion
from the whole experiment down to a level of fine
structure. To provide further evidence of disease rele-
vance and biological content contained in both the
human and mouse gene sets hierarchical clustering
was performed on both human and mouse. Four hun-
dred and eighty human gene sets were clustered pro-
ducing 46 major disease clusters. In the mouse,
clustering was performed on 2067 mouse phenotype
gene sets, using gene sets containing at least 3 genes.
This resulted in 165 major subgroups of functional
phenotypic specificity. Hierarchical clustering is shown
for human [Additional file 1 and Additional file 2] and
for mouse [Additional file 3 and Additional file 4].
Like the human and mouse dendograms, this hierarch-
ical clustering showed functional disease grouping at
both a coarse group level and at a fine level within
major phenotypic groupings. These clusters in both
human and mouse falling into closely defined broad
functional groups as well as closely related clinical,
physiological, and developmental phenotypes demon-
strates a general pattern of relevance to disease in
their original underlying genetic associations. As in the
dendrogram displays, this suggests that the genes nom-
inally positively associated to these disorders, drawn
from the medical literature, are not pervasively ran-
domly assigned or due to a widespread pattern of ran-
dom false positives associations.
Discussion and Conclusion
This report describes a summary of the positive genetic
associations to disease phenotypes found in the Genetic
Association Database as well as a summary of mouse
genetically determined phenotypes from the MGI phe-
notypes database. The genes and disease lists described
here were derived from a broad literature mining
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Figure 1 Venn Diagram analysis of individual GAD disease gene sets (circles) versus pathways (rectangles) produced from the
corresponding gene set. All Venn Diagrams were produced with Venny http://bioinfogp.cnb.csic.es/tools/venny/index.html.
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Figure 2 Human dendrogram comparison of 480 GAD disease gene sets based on gene sharing. The input GAD gene set file for this
figure can be found in Table S6[46].
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Page 18 of 22approach. We have shown disease relevance in three
distinct ways; a) in comparing individual gene lists and
pathways, b) comparing between species and, c) in
broad based comparative analysis utilizing complex sys-
tems approaches. Moreover, we identify disease based
genes sets for 1,317 human disease phenotypes as well
as 5,142 mouse experimentally determined phenotypes.
These resources are the largest gene set files currently
publicly available and the only gene set files derived
from population based human epidemiological genetic
studies and mouse genetic models of disease.
Each individual GAD disease gene set (i.e. a single dis-
ease term followed by a string of genes) or mouse phe-
notype gene set becomes a candidate for a number of
uses and applications including:
a) contributing to complex (additive, multiplicative,
gene-environment) statistical models for any given dis-
ease phenotype [49-53]; b) use in comparative analysis
of disease between disease phenotypes; c) use in interro-
gating other related data types, such as microarray (see
below), proteomic, or SNP data [54-56]; and d) integra-
tion into annotation engines[57] or genome browsers
Figure 3 Mouse dendrogram comparison of 1056 mouse phenotype (MP) gene sets based on gene sharing. The input MP gene set file
for this figure can be found in Table S7[47].
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tion in comparative genomic analysis. In a sense, each
individual human or mouse disease/phenotype gene set
becomes a unique hypothesis, testable in a variety of
ways. Increasingly, combinations of genes may have
important predictive value as combinatorial biomarkers
in predicting disease risk as opposed to single candidate
genes [59,60].
In addition, in an ongoing parallel set of experiments,
using a Gene Set Analysis (GSA) approach using the
web tool Disease/Phenotype web-PAGE, in the analysis
of orthologous microarray data (De S, Zhang Y, Garner
JR, Wang SA, Becker KG: Disease and phenotype gene
set analysis of disease based gene expression, unpub-
lished), both the human and mouse disease/phenotype
gene sets defined above demonstrate striking disease
specificity in PAGE[61] gene set analysis of previously
published microarray based gene expression studies
from numerous independent laboratories in both a spe-
cies specific and cross species manner. This was true
when studying gene expression studies of type 2 dia-
betes, obesity, myocardial infarction and sepsis, among
others, providing further evidence of the disease and
clinical relevance of both the human and mouse gene
sets.
This approach is limited in a number of ways. In par-
ticular, the GAD database compares the results of
human population based epidemiological studies per-
formed using different sample sizes, populations, statisti-
cal models, and at different times over approximately
the last 16 years. In addition, the GAD database draws
on association studies of broad quality with different
degrees of detail provided. Although all human genetic
association studies discussed here have been individually
determined to be positively associated with a disease or
phenotype in a peer reviewed journal, we make no
assertion that any individual study is correct and we
recognize the controversy in the genetics community
regarding statistical and biological significance of genetic
association studies. Moreover, although the GAD data-
base contains information on polymorphism and varia-
tion, and each GAD record is fundamentally based on
polymorphism, this report does not consider variation
or polymorphism in the summaries shown. Likewise,
mouse genetic models in many cases are weighted to
gene knockouts which may not be necessarily be directly
representative of multifactorial human common com-
plex disease.
However, even with these limitations, we believe valu-
able insights can be gained from broad based literature
assessments of the genetic contribution in human com-
mon complex disease and in mouse phenotypic biology.
More importantly, this suggests greater opportunities
for systematic mining and analysis of published data and
in cross comparison of archival molecular databases in
both human and animal models of disease with regard
to genetic variation, population comparisons, and inte-
gration with many different types of orthologous
information.
Additional file 1: Hierarchical clustering of 480 Human GAD disease
gene sets. This file contains a display of hierarchical clustering of 480
Human GAD disease gene sets, each gene set contain at least 3 genes
each.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-8794-3-1-
S1.PDF]
Additional file 2: Individual human disease functional clusters. This
file contains selected subsets of Additional File 1 including; a.
tumorigenesis, b. autoimmune, c. cardiovascular, d. metabolism, and e.
behavior.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-8794-3-1-
S2.PDF]
Additional file 3: Hierarchical clustering of 2067 Mouse phenotypic
gene sets. This file contains a display of hierarchical clustering of 2067
Mouse phenotypic gene sets, each gene set contain at least 10 genes
each.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-8794-3-1-
S3.PDF]
Additional file 4: Individual mouse phenotypic functional clusters.
This file contains selected subsets of Additional File 2 including; a.
immune function, b. metabolism, c. neurological function/behavior, d.
DNA replication/tumorigenesis, e. development and f. cardiovascular.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-8794-3-1-
S4.PDF]
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